Toni Ibrahim Osteoncology and Rare Tumors Center Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy Biography Publications Institution JoVE Articles Toni Ibrahim has not added a biography. If you are Toni Ibrahim and would like to personalize this page please email our Author Liaison for assistance. Publications Myxofibrosarcoma Primary Cultures: Molecular and Pharmacological Profile Therapeutic Advances in Medical Oncology. Dec, 2017 | Pubmed ID: 29449896 Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents International Journal of Molecular Sciences. Dec, 2017 | Pubmed ID: 29292724 Osteoblastic Bone Metastases from Neuroendocrine Tumor (NET) of Unknown Origin Detected by 18fluorocholine PET/CT and Its Comparison with 68gallium-DOTATOC PET/CT: Case Report and Review of the Literature Medicine. Nov, 2017 | Pubmed ID: 29145267 Primary Leiomyosarcoma of the Bone: a Case Report and a Review of the Literature Medicine. Nov, 2017 | Pubmed ID: 29137065 Management and Potentialities of Primary Cancer Cultures in Preclinical and Translational Studies Journal of Translational Medicine. Nov, 2017 | Pubmed ID: 29116016 Epidemiology and Survival Analysis of Gastrointestinal Stromal Tumors in Lebanon: Real-life Study from a Hospital Tumor Registry 2000-2015 The Gulf Journal of Oncology. May, 2017 | Pubmed ID: 28798000 Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition International Journal of Molecular Sciences. 07, 2017 | Pubmed ID: 28758931 Prognostic Impact of the Cumulative Dose and Dose Intensity of Everolimus in Patients with Pancreatic Neuroendocrine Tumors Cancer Medicine. Jul, 2017 | Pubmed ID: 28547856 Update on the Role of Trabectedin in the Treatment of Intractable Soft Tissue Sarcomas OncoTargets and Therapy. 2017 | Pubmed ID: 28260930 CORRECTION: Innovative Approaches to Establish and Characterize Primary Cultures: an Ex Vivo 3D System and the Zebrafish Model Biology Open. Feb, 2017 | Pubmed ID: 28202474 PET/CT Scanner and Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma PloS One. 2017 | Pubmed ID: 28099514 Everolimus in Pancreatic Neuroendocrine Carcinomas G3 Pancreas. Mar, 2017 | Pubmed ID: 28099254 Vitamin D Receptor Polymorphisms or Serum Levels As Key Drivers of Breast Cancer Development? The Question of the Vitamin D Pathway Oncotarget. Feb, 2017 | Pubmed ID: 28061456 Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of (18)FDG-PET/CT Clinical Lung Cancer. Jul, 2017 | Pubmed ID: 27956089 The Role of 68Ga-DOTA-NOC PET/CT in Evaluating Neuroendocrine Tumors: Real-world Experience from Two Large Neuroendocrine Tumor Centers Nuclear Medicine Communications. Feb, 2017 | Pubmed ID: 27922538 Splicing Factor Ratio As an Index of Epithelial-mesenchymal Transition and Tumor Aggressiveness in Breast Cancer Oncotarget. Jan, 2017 | Pubmed ID: 27911856 Innovative Approaches to Establish and Characterize Primary Cultures: an Ex Vivo 3D System and the Zebrafish Model Biology Open. Feb, 2017 | Pubmed ID: 27895047 Recombinant Granulocyte Colony-stimulating Factor (rG-CSF) in the Management of Neutropenia Induced by Anthracyclines and Ifosfamide in Patients with Soft Tissue Sarcomas (NEUSAR) Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. Jan, 2017 | Pubmed ID: 27568305 Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma Molecules (Basel, Switzerland). Dec, 2016 | Pubmed ID: 27918490 The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts International Journal of Molecular Sciences. Nov, 2016 | Pubmed ID: 27809291 Current Classification, Treatment Options, and New Perspectives in the Management of Adipocytic Sarcomas OncoTargets and Therapy. 2016 | Pubmed ID: 27785071 RANKL: A Promising Circulating Marker for Bone Metastasis Response Oncology Letters. Oct, 2016 | Pubmed ID: 27698885 [Corrigendum] Cisplatin in Combination with Zoledronic Acid: A Synergistic Effect in Triple-negative Breast Cancer Cell Lines International Journal of Oncology. 09, 2016 | Pubmed ID: 27573164 Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model International Journal of Molecular Sciences. Aug, 2016 | Pubmed ID: 27556456 Characteristics of Incident Testicular Cancer in Lebanon - 1990-2015 Single Institutional Experience Asian Pacific Journal of Cancer Prevention : APJCP. 2016 | Pubmed ID: 27221873 Tirofiban-Induced Thrombocytopenia Occurring with Crohn's Disease Case Reports in Cardiology. 2016 | Pubmed ID: 27144035 Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases Scientific Reports. Apr, 2016 | Pubmed ID: 27079142 Distribution and Correlates of Non-high-density Lipoprotein Cholesterol and Triglycerides in Lebanese School Children Journal of Clinical Lipidology. Mar-Apr, 2016 | Pubmed ID: 27055969 Treatment of Cancer Patients in Their Last Month of Life: Aimless Chemotherapy Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. Apr, 2016 | Pubmed ID: 26391890 Long-lasting Activity of Trabectedin in Refractory Uterine Leiomyosarcoma: a Case Report BMC Cancer. Dec, 2015 | Pubmed ID: 26695071 Natural History of Non-Small-Cell Lung Cancer with Bone Metastases Scientific Reports. Dec, 2015 | Pubmed ID: 26690845 First-line Chemotherapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma OncoTargets and Therapy. 2015 | Pubmed ID: 26664145 Paraneoplastic Hypocalcemia-induced Heart Failure in Advanced Breast Cancer: A Case Report and Literature Review Oncology Letters. Aug, 2015 | Pubmed ID: 26622568 Feasibility and Utility of Re-treatment with (177)Lu-DOTATATE in GEP-NENs Relapsed After Treatment with (90)Y-DOTATOC European Journal of Nuclear Medicine and Molecular Imaging. Dec, 2015 | Pubmed ID: 26112388 Hypocalcaemia in Patients with Metastatic Bone Disease Treated with Denosumab European Journal of Cancer (Oxford, England : 1990). Sep, 2015 | Pubmed ID: 26093811 Progesterone Receptor Status and Clinical Outcome in Breast Cancer Patients with Estrogen Receptor-positive Locoregional Recurrence Tumori. Jul-Aug, 2015 | Pubmed ID: 26045108 Efficacy of Endocrine Therapy in Relation to Progesterone Receptor and Ki67 Expression in Advanced Breast Cancer Breast Cancer Research and Treatment. Jul, 2015 | Pubmed ID: 26012644 Bone Metastases in Patients with Metastatic Renal Cell Carcinoma: Are They Always Associated with Poor Prognosis? Journal of Experimental & Clinical Cancer Research : CR. Feb, 2015 | Pubmed ID: 25651794 Pleural Effusion in a Patient with Metastatic Gastrointestinal Stromal Tumor Treated with Imatinib: Case Report Future Oncology (London, England). Dec, 2014 | Pubmed ID: 25525851 Metronomic Capecitabine in Gastroenteropancreatic Neuroendrocrine Tumors: a Suitable Regimen and Review of the Literature OncoTargets and Therapy. 2014 | Pubmed ID: 25364262 Single Bone Metastasis from Adenocarcinoma of the Lacrimal Gland: a Case Report Future Oncology (London, England). Aug, 2014 | Pubmed ID: 25303054 ΔNp63 Promotes Stem Cell Activity in Mammary Gland Development and Basal-like Breast Cancer by Enhancing Fzd7 Expression and Wnt Signalling Nature Cell Biology. Oct, 2014 | Pubmed ID: 25241036 Natural History of Malignant Bone Disease in Hepatocellular Carcinoma: Final Results of a Multicenter Bone Metastasis Survey PloS One. 2014 | Pubmed ID: 25170882 The MicroRNA-23b/27b/24 Cluster Promotes Breast Cancer Lung Metastasis by Targeting Metastasis-suppressive Gene Prosaposin The Journal of Biological Chemistry. Aug, 2014 | Pubmed ID: 24966325 CSF-1 Blockade Impairs Breast Cancer Osteoclastogenic Potential in Co-culture Systems Bone. Sep, 2014 | Pubmed ID: 24956020 Targeting Bone Metastatic Cancer: Role of the MTOR Pathway Biochimica Et Biophysica Acta. Apr, 2014 | Pubmed ID: 24508774 Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey PloS One. 2013 | Pubmed ID: 24386138 Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey PloS One. 2013 | Pubmed ID: 24204569 A New Emergency in Oncology: Bone Metastases in Breast Cancer Patients (Review) Oncology Letters. Aug, 2013 | Pubmed ID: 24137321 Tumor-Induced Osteoclast MiRNA Changes As Regulators and Biomarkers of Osteolytic Bone Metastasis Cancer Cell. Oct, 2013 | Pubmed ID: 24135284 Bone and Cancer: the Osteoncology Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases. May, 2013 | Pubmed ID: 24133529 What Can We Learn from the ZOOM Trial?--Authors' Reply The Lancet. Oncology. Sep, 2013 | Pubmed ID: 23993381 RANK/RANK-L/OPG in Patients with Bone Metastases Treated with Anticancer Agents and Zoledronic Acid: a Prospective Study International Journal of Molecular Sciences. May, 2013 | Pubmed ID: 23702841 Efficacy and Safety of 12-weekly Versus 4-weekly Zoledronic Acid for Prolonged Treatment of Patients with Bone Metastases from Breast Cancer (ZOOM): a Phase 3, Open-label, Randomised, Non-inferiority Trial The Lancet. Oncology. Jun, 2013 | Pubmed ID: 23684411 Metastatic Bone Disease in the Era of Bone-targeted Therapy: Clinical Impact Tumori. Jan-Feb, 2013 | Pubmed ID: 23548992 Cisplatin in Combination with Zoledronic Acid: a Synergistic Effect in Triple-negative Breast Cancer Cell Lines International Journal of Oncology. Apr, 2013 | Pubmed ID: 23403907 MiR-126 and MiR-126* Repress Recruitment of Mesenchymal Stem Cells and Inflammatory Monocytes to Inhibit Breast Cancer Metastasis Nature Cell Biology. Mar, 2013 | Pubmed ID: 23396050 Trastuzumab-induced Cardiotoxicity in Early Breast Cancer Patients: a Retrospective Study of Possible Risk and Protective Factors Heart (British Cardiac Society). May, 2013 | Pubmed ID: 23349345 Hormonal Receptor, Human Epidermal Growth Factor Receptor-2, and Ki67 Discordance Between Primary Breast Cancer and Paired Metastases: Clinical Impact Oncology. 2013 | Pubmed ID: 23257904 Inhibition of Breast Cancer Cell Proliferation in Repeated and Non-repeated Treatment with Zoledronic Acid Cancer Cell International. Nov, 2012 | Pubmed ID: 23173568 Elf5 Inhibits the Epithelial-mesenchymal Transition in Mammary Gland Development and Breast Cancer Metastasis by Transcriptionally Repressing Snail2 Nature Cell Biology. Nov, 2012 | Pubmed ID: 23086238 Time-dependent Pharmacokinetics of 5-fluorouracil and Association with Treatment Tolerability in the Adjuvant Setting of Colorectal Cancer Journal of Clinical Pharmacology. Mar, 2012 | Pubmed ID: 21383342 Direct Targeting of Sec23a by MiR-200s Influences Cancer Cell Secretome and Promotes Metastatic Colonization Nature Medicine. Sep, 2011 | Pubmed ID: 21822286 Role of RANK, RANKL, OPG, and CXCR4 Tissue Markers in Predicting Bone Metastases in Breast Cancer Patients Clinical Breast Cancer. Dec, 2011 | Pubmed ID: 21764390 The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: a Pilot Study Oncology. 2011 | Pubmed ID: 21734413 Bone Metastases Detection by Circulating Biomarkers: OPG and RANK-L International Journal of Oncology. Jul, 2011 | Pubmed ID: 21491082 Pathogenesis of Osteoblastic Bone Metastases from Prostate Cancer Cancer. Mar, 2010 | Pubmed ID: 20108337 Can We Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting Current Cancer Drug Targets. Feb, 2010 | Pubmed ID: 20088792 A Phase IB Dose-finding Trial of Liposomal Doxorubicin in Combination with Capecitabine in Patients with Pretreated Metastatic Breast Cancer Cancer Chemotherapy and Pharmacology. Apr, 2010 | Pubmed ID: 19693503 Multidisciplinary Approach to the Treatment of Bone Metastases: Osteo-Oncology Center, a New Organizational Model Tumori. May-Jun, 2009 | Pubmed ID: 19688966 Osteonecrosis of the Jaw in Patients with Bone Metastases Treated with Bisphosphonates: a Retrospective Study The Oncologist. Mar, 2008 | Pubmed ID: 18378544 Improved Analysis of 5-Fluorouracil and 5,6-dihydro-5-Fluorouracil by HPLC with Diode Array Detection for Determination of Cellular Dihydropyrimidine Dehydrogenase Activity and Pharmacokinetic Profiling Therapeutic Drug Monitoring. Jun, 2005 | Pubmed ID: 15905808 Innovative Sequence of Docetaxel-gemcitabine Based on Preclinical Data in the Treatment of Advanced Non Small Cell Lung Cancer: a Phase I Study Lung Cancer (Amsterdam, Netherlands). Feb, 2005 | Pubmed ID: 15639725 Limited Sampling Model for the Analysis of 5-fluorouracil Pharmacokinetics in Adjuvant Chemotherapy for Colorectal Cancer Clinical Pharmacology and Therapeutics. Dec, 2002 | Pubmed ID: 12496744 Relationship Between Plasma Concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and Toxicity of 5-fluorouracil Infusions in Cancer Patients Therapeutic Drug Monitoring. Oct, 2002 | Pubmed ID: 12352929 Docetaxel Followed by Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer: a Phase I Study Tumori. Mar-Apr, 2002 | Pubmed ID: 12088266 "Misura" Project: a Retrospective Survey on the Use of 5fluorouracil in the Treatment of Colorectal Cancer in 24 Italian Clinical Centers Tumori. Mar-Apr, 2002 | Pubmed ID: 12088248 Tørket blod og Serum flekker som et nyttig verktøy for eksempel Storage evaluere kreft Biomarkers Laura Mercatali1, Patrizia Serra2, Giacomo Miserocchi1, Chiara Spadazzi1, Chiara Liverani1, Alessandro De Vita1, Giorgia Marisi3, Alberto Bongiovanni1, Federica Recine1, Akwilina Pangan4, Nestory Masalu4, Toni Ibrahim1, Dino Amadori1 1Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, 2Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, 3Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, 4Department of Oncology, Bugando Medical Center, Mwanza, Tanzania JoVE 57113 Cancer Research Etablering av en primære kultur for pasient-avledede bløtvev sarkom Alessandro De Vita1, Laura Mercatali1, Giacomo Miserocchi1, Chiara Liverani1, Chiara Spadazzi1, Federica Recine1, Alberto Bongiovanni1, Federica Pieri2, Davide Cavaliere3, Valentina Fausti1, Dino Amadori1, Toni Ibrahim1 1Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 2Pathology Unit, Morgagni-Pierantoni Hospital, 3Unit of Surgery and Advanced Oncologic Therapies, Morgagni-Pierantoni Hospital JoVE 56767 Cancer Research Utviklingen av en menneskelig prekliniske modell av Osteoclastogenesis fra perifert blod monocytter co kultivert med bryst kreftcelle linjer Laura Mercatali1, Chiara Spadazzi1, Giacomo Miserocchi1, Chiara Liverani1, Alessandro De Vita1, Alberto Bongiovanni1, Federica Recine1, Dino Amadori1, Toni Ibrahim1 1Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS JoVE 56311 Cancer Research
Tørket blod og Serum flekker som et nyttig verktøy for eksempel Storage evaluere kreft Biomarkers Laura Mercatali1, Patrizia Serra2, Giacomo Miserocchi1, Chiara Spadazzi1, Chiara Liverani1, Alessandro De Vita1, Giorgia Marisi3, Alberto Bongiovanni1, Federica Recine1, Akwilina Pangan4, Nestory Masalu4, Toni Ibrahim1, Dino Amadori1 1Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, 2Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, 3Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, 4Department of Oncology, Bugando Medical Center, Mwanza, Tanzania JoVE 57113 Cancer Research
Etablering av en primære kultur for pasient-avledede bløtvev sarkom Alessandro De Vita1, Laura Mercatali1, Giacomo Miserocchi1, Chiara Liverani1, Chiara Spadazzi1, Federica Recine1, Alberto Bongiovanni1, Federica Pieri2, Davide Cavaliere3, Valentina Fausti1, Dino Amadori1, Toni Ibrahim1 1Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 2Pathology Unit, Morgagni-Pierantoni Hospital, 3Unit of Surgery and Advanced Oncologic Therapies, Morgagni-Pierantoni Hospital JoVE 56767 Cancer Research
Utviklingen av en menneskelig prekliniske modell av Osteoclastogenesis fra perifert blod monocytter co kultivert med bryst kreftcelle linjer Laura Mercatali1, Chiara Spadazzi1, Giacomo Miserocchi1, Chiara Liverani1, Alessandro De Vita1, Alberto Bongiovanni1, Federica Recine1, Dino Amadori1, Toni Ibrahim1 1Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS JoVE 56311 Cancer Research
